App is temporarily unavailable
Description
Die DIFA1 App dient der COVID-19 Impfbegleitung. Über einen intelligenten Chatbot werden bei geimpften Personen regelmässig Daten zu Wirksamkeit und Sicherheit der Impfung erfragt. Zudem werden geimpfte Personen automatisch an die 2. Impfung erinnert. Die erhobenen Daten werden anschliessend mit Einverständnis der Nutzer deidentifiziert automatisch an ausgesuchte Forschungsinstitute zum Zwecke einer Kohortenstudie weitergegeben.
Wir würden uns sehr freuen von Ihnen zu hören. Wenn Sie Feedback oder Fragen haben, erreichen Sie uns unter [email protected]
Hide
Show More...
Wir würden uns sehr freuen von Ihnen zu hören. Wenn Sie Feedback oder Fragen haben, erreichen Sie uns unter [email protected]
Screenshots
DIFA1 FAQ
-
Is DIFA1 free?
Yes, DIFA1 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is DIFA1 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does DIFA1 cost?
DIFA1 is free.
-
What is DIFA1 revenue?
To get estimated revenue of DIFA1 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in France yet.
Ratings History
DIFA1 Reviews
DIFA1 Installs
Last 30 days
DIFA1 Revenue
Last 30 daysDIFA1 Revenue and Downloads
Gain valuable insights into DIFA1 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
-
docjo
- Languages
- English
- Recent release
- 1.2.5 (3 years ago )
- Released on
- Jan 14, 2021 (3 years ago )
- Also available in
- Germany , Australia , Austria , United States , Canada , Colombia , Spain , France , Sweden , Philippines , India , New Zealand , Vietnam , Thailand , Pakistan , Netherlands , Malaysia , Italy , Israel , Ireland , United Kingdom , Dominican Republic , Brazil , Azerbaijan
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.